Handelsbanken Fonder AB - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 300 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.

Quarter-by-quarter ownership
Handelsbanken Fonder AB ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$430
-22.5%
13,6000.0%0.00%
-33.3%
Q2 2023$555
+37.7%
13,600
+25.9%
0.00%
+50.0%
Q1 2023$403
+6.9%
10,8000.0%0.00%0.0%
Q4 2022$377
-99.9%
10,800
+13.7%
0.00%
-50.0%
Q3 2022$532,000
+8.1%
9,5000.0%0.00%
+33.3%
Q2 2022$492,000
-28.7%
9,5000.0%0.00%
-25.0%
Q1 2022$690,000
-48.8%
9,500
-16.7%
0.00%
-42.9%
Q4 2021$1,348,000
-28.2%
11,400
-18.6%
0.01%
-30.0%
Q3 2021$1,878,000
+127.1%
14,000
+35.9%
0.01%
+100.0%
Q1 2021$827,000
+55.2%
10,300
+5.1%
0.01%
+66.7%
Q4 2020$533,0009,8000.00%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. 1,216,340$62,958,0007.04%
Discovery Value Fund 584,483$30,253,0006.33%
MPM BioImpact LLC 299,409$15,497,0004.30%
ARK Investment Management 9,514,580$439,003,0002.60%
Elmwood Wealth Management, Inc. 67,899$3,514,0002.00%
Nikko Asset Management Americas, Inc. 2,781,136$141,143,0001.74%
Avidity Partners Management LP 1,125,194$58,240,0001.34%
Merlin Capital, Inc 12,174$630,0001.26%
Atlas Venture Associates IX, LLC 10,000$518,0001.18%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 111,440$5,768,0001.16%
View complete list of INTELLIA THERAPEUTICS INC shareholders